Abstract
Sesquiterpene lactones (SLs) are biologically active compounds found in various medicinal plants. Although the compounds are reported to possess numerous biological activities, but the most important is their immunoregulatory role in inflammatory cells. This is because 1) over-activation of inflammatory cells secretes a large amount of different pro-inflammatory mediators such as cytokines, nitric oxide (NO) and prostaglandin (PG)E2 and 2) SLs can modulate these phenomena effectively through inhibiting the activation pathway of nuclear factor (NF)-κB via the reactivity of some functional groups in SLs such as α-methylene-γ- lactone. This review, therefore, discusses in detail the molecular mechanism and structural features of SLs in blocking NF-κB activation with a general introduction of NF-κB and proposes the possibility that SLs can be developed pharmaceutically useful drugs against NF-κB-mediated diseases and that they can be chemically modified to improve their anti-NF-κB efficacy.
Keywords: Sesquiterpene lactones, NF-κB, I-κB, cytokines, inflammatory mediators, structure-activity relationship study
Current Enzyme Inhibition
Title: Sesquiterpene Lactones as a Potent Class of NF-κB Activation Inhibitors
Volume: 2 Issue: 4
Author(s): Jae Youl Cho
Affiliation:
Keywords: Sesquiterpene lactones, NF-κB, I-κB, cytokines, inflammatory mediators, structure-activity relationship study
Abstract: Sesquiterpene lactones (SLs) are biologically active compounds found in various medicinal plants. Although the compounds are reported to possess numerous biological activities, but the most important is their immunoregulatory role in inflammatory cells. This is because 1) over-activation of inflammatory cells secretes a large amount of different pro-inflammatory mediators such as cytokines, nitric oxide (NO) and prostaglandin (PG)E2 and 2) SLs can modulate these phenomena effectively through inhibiting the activation pathway of nuclear factor (NF)-κB via the reactivity of some functional groups in SLs such as α-methylene-γ- lactone. This review, therefore, discusses in detail the molecular mechanism and structural features of SLs in blocking NF-κB activation with a general introduction of NF-κB and proposes the possibility that SLs can be developed pharmaceutically useful drugs against NF-κB-mediated diseases and that they can be chemically modified to improve their anti-NF-κB efficacy.
Export Options
About this article
Cite this article as:
Youl Cho Jae, Sesquiterpene Lactones as a Potent Class of NF-κB Activation Inhibitors, Current Enzyme Inhibition 2006; 2 (4) . https://dx.doi.org/10.2174/157340806778699299
DOI https://dx.doi.org/10.2174/157340806778699299 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
Current Signal Transduction Therapy Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents
Current Pharmaceutical Design Placebo Preparation for the Proper Clinical Trial of Herbal Medicine - Requirements, Verification and Quality Control
Recent Patents on Inflammation & Allergy Drug Discovery RNA Base Damage and Repair
Current Pharmaceutical Biotechnology Protein Kinase C-θ (PKCθ), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias
Current Cancer Drug Targets New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Cardioembolic Stroke Diagnosis Using Blood Biomarkers
Current Cardiology Reviews Biological and Chemical Aspects of Natural Biflavonoids from Plants: A Brief Review
Mini-Reviews in Medicinal Chemistry Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review
Current Drug Therapy Use of Amino Acids as Counterions Improves the Solubility of the BCS II Model Drug, Indomethacin
Current Drug Delivery MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy
Inflammation & Allergy - Drug Targets (Discontinued) Other Potential Therapeutic Targets in Thyroid Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Role of Secretory Phospholipase A2 in CNS Inflammation: Implications in Traumatic Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery Review of Erectile Dysfunction in Diabetic Animal Models
Current Diabetes Reviews Myelin Sheaths and Autoimmune Response Induced by Myelin Proteins and Alphaviruses. I. Physicochemical Background
Current Medicinal Chemistry A Possible Role for Interleukin 37 in the Pathogenesis of Behcet's Disease
Current Molecular Medicine The Role of Maternal Serum Biomarkers in the Early Diagnosis of Ectopic Pregnancy
Current Chemical Biology Protection of Blood Brain Barrier Integrity and Modulation of Inflammatory Mediators During Treatment of Pneumococcal Meningitis with Daptomycin or Ceftriaxone
Current Neurovascular Research